Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · November 08, 2020

Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion After Brolucizumab Treatment

Ophthalmology Retina

 

Additional Info

Ophthalmology Retina
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and/or Vascular Occlusion After Brolucizumab Treatment
Ophthalmol Retina 2020 Sep 29;[EPub Ahead of Print], CR Baumal, B Bodaghi, M Singer, DJ Tanzer, A Seres, MR Joshi, N Feltgen, R Gale

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading